Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
tosedostat
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT00780598
2012-06-28
OPAL
Chroma Therapeutics
Phase 2
Completed
76 enrolled